These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 23318649)

  • 1. Ablation of the microglial protein DOCK2 reduces amyloid burden in a mouse model of Alzheimer's disease.
    Cimino PJ; Yang Y; Li X; Hemingway JF; Cherne MK; Khademi SB; Fukui Y; Montine KS; Montine TJ; Keene CD
    Exp Mol Pathol; 2013 Apr; 94(2):366-71. PubMed ID: 23318649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DOCK2 is a microglial specific regulator of central nervous system innate immunity found in normal and Alzheimer's disease brain.
    Cimino PJ; Sokal I; Leverenz J; Fukui Y; Montine TJ
    Am J Pathol; 2009 Oct; 175(4):1622-30. PubMed ID: 19729484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of the type-1 interferon receptor in APPSWE/PS1ΔE9 mice preserves cognitive function and alters glial phenotype.
    Minter MR; Moore Z; Zhang M; Brody KM; Jones NC; Shultz SR; Taylor JM; Crack PJ
    Acta Neuropathol Commun; 2016 Jul; 4(1):72. PubMed ID: 27400725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressed accumulation of cerebral amyloid {beta} peptides in aged transgenic Alzheimer's disease mice by transplantation with wild-type or prostaglandin E2 receptor subtype 2-null bone marrow.
    Keene CD; Chang RC; Lopez-Yglesias AH; Shalloway BR; Sokal I; Li X; Reed PJ; Keene LM; Montine KS; Breyer RM; Rockhill JK; Montine TJ
    Am J Pathol; 2010 Jul; 177(1):346-54. PubMed ID: 20522650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of the prostaglandin E2 EP2 receptor reduces oxidative damage and amyloid burden in a model of Alzheimer's disease.
    Liang X; Wang Q; Hand T; Wu L; Breyer RM; Montine TJ; Andreasson K
    J Neurosci; 2005 Nov; 25(44):10180-7. PubMed ID: 16267225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Chronic Paroxetine Treatment in Mitigating Amyloid Pathology and Microgliosis in APPSWE/PS1ΔE9 Transgenic Mice.
    Sivasaravanaparan M; Olesen LØ; Severino M; von Linstow CU; Lambertsen KL; Gramsbergen JB; Hasselstrøm J; Metaxas A; Wiborg O; Finsen B
    J Alzheimers Dis; 2022; 87(2):685-699. PubMed ID: 35342093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated Abeta deposition in APPswe/PS1deltaE9 mice with hemizygous deletions of TTR (transthyretin).
    Choi SH; Leight SN; Lee VM; Li T; Wong PC; Johnson JA; Saraiva MJ; Sisodia SS
    J Neurosci; 2007 Jun; 27(26):7006-10. PubMed ID: 17596449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model.
    Meilandt WJ; Ngu H; Gogineni A; Lalehzadeh G; Lee SH; Srinivasan K; Imperio J; Wu T; Weber M; Kruse AJ; Stark KL; Chan P; Kwong M; Modrusan Z; Friedman BA; Elstrott J; Foreman O; Easton A; Sheng M; Hansen DV
    J Neurosci; 2020 Feb; 40(9):1956-1974. PubMed ID: 31980586
    [No Abstract]   [Full Text] [Related]  

  • 9. Ube3a deficiency inhibits amyloid plaque formation in APPswe/PS1δE9 mouse model of Alzheimer's disease.
    Singh BK; Vatsa N; Kumar V; Shekhar S; Sharma A; Jana NR
    Hum Mol Genet; 2017 Oct; 26(20):4042-4054. PubMed ID: 29016862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voluntary Running Attenuates Memory Loss, Decreases Neuropathological Changes and Induces Neurogenesis in a Mouse Model of Alzheimer's Disease.
    Tapia-Rojas C; Aranguiz F; Varela-Nallar L; Inestrosa NC
    Brain Pathol; 2016 Jan; 26(1):62-74. PubMed ID: 25763997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel retro-inverso peptide inhibitor reduces amyloid deposition, oxidation and inflammation and stimulates neurogenesis in the APPswe/PS1ΔE9 mouse model of Alzheimer's disease.
    Parthsarathy V; McClean PL; Hölscher C; Taylor M; Tinker C; Jones G; Kolosov O; Salvati E; Gregori M; Masserini M; Allsop D
    PLoS One; 2013; 8(1):e54769. PubMed ID: 23382963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOE3, but not APOE4, bone marrow transplantation mitigates behavioral and pathological changes in a mouse model of Alzheimer disease.
    Yang Y; Cudaback E; Jorstad NL; Hemingway JF; Hagan CE; Melief EJ; Li X; Yoo T; Khademi SB; Montine KS; Montine TJ; Keene CD
    Am J Pathol; 2013 Sep; 183(3):905-17. PubMed ID: 23831297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model.
    Baik SH; Kang S; Son SM; Mook-Jung I
    Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early chronic suppression of microglial p38α in a model of Alzheimer's disease does not significantly alter amyloid-associated neuropathology.
    Braun DJ; Frazier HN; Davis VA; Coleman MJ; Rogers CB; Van Eldik LJ
    PLoS One; 2023; 18(5):e0286495. PubMed ID: 37256881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progranulin protects against amyloid β deposition and toxicity in Alzheimer's disease mouse models.
    Minami SS; Min SW; Krabbe G; Wang C; Zhou Y; Asgarov R; Li Y; Martens LH; Elia LP; Ward ME; Mucke L; Farese RV; Gan L
    Nat Med; 2014 Oct; 20(10):1157-64. PubMed ID: 25261995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An anti-pyroglutamate-3 Aβ vaccine reduces plaques and improves cognition in APPswe/PS1ΔE9 mice.
    Frost JL; Liu B; Rahfeld JU; Kleinschmidt M; O'Nuallain B; Le KX; Lues I; Caldarone BJ; Schilling S; Demuth HU; Lemere CA
    Neurobiol Aging; 2015 Dec; 36(12):3187-3199. PubMed ID: 26453001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E2 receptor subtype 2 regulation of scavenger receptor CD36 modulates microglial Aβ42 phagocytosis.
    Li X; Melief E; Postupna N; Montine KS; Keene CD; Montine TJ
    Am J Pathol; 2015 Jan; 185(1):230-9. PubMed ID: 25452117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained Alzheimer's amyloid pathology in myeloid differentiation protein-88-deficient APPswe/PS1 mice.
    Goll Y; Bekenstein U; Barbash S; Greenberg DS; Zangen R; Shoham S; Soreq H
    Neurodegener Dis; 2014; 13(2-3):58-60. PubMed ID: 24192711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of LR11/SORLA enhances early pathology in a mouse model of amyloidosis: evidence for a proximal role in Alzheimer's disease.
    Dodson SE; Andersen OM; Karmali V; Fritz JJ; Cheng D; Peng J; Levey AI; Willnow TE; Lah JJ
    J Neurosci; 2008 Nov; 28(48):12877-86. PubMed ID: 19036982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of CRFR1 Ablation on Amyloid-β Production and Accumulation in a Mouse Model of Alzheimer's Disease.
    Campbell SN; Zhang C; Roe AD; Lee N; Lao KU; Monte L; Donohue MC; Rissman RA
    J Alzheimers Dis; 2015; 45(4):1175-84. PubMed ID: 25697705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.